Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme
Overview
This resource outlines the PATHWAY research programme, which investigated the integration of metacognitive therapy (MCT) into cardiac rehabilitation to address anxiety and depression in cardiovascular disease patients. It summarizes findings from feasibility trials, qualitative studies, and a definitive randomized controlled trial involving 332 participants, noting that group-based MCT led to greater reductions in psychological distress compared to standard care alone. The text is intended for readers interested in clinical research methodologies and the application of psychological interventions within cardiac care settings.
- ID
0bebbc4e61314a5e- Source org
- PubMed Central
- Author
- Not recorded
- Published
- Not recorded
- OA status
- Not recorded
- DOI
- 10.3389/fpsyt.2022.886407
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- Not recorded
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 1 · checked_at unknown
- linkok via http-check · 2026-07-28T03:58:44.050956+00:00
Cite this entry
BibTeX
@article{allodium:0bebbc4e61314a5e,
title = {Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme},
journal = {PubMed Central},
doi = {10.3389/fpsyt.2022.886407},
url = {https://doi.org/10.3389/fpsyt.2022.886407}
}RIS
TY - JOUR TI - Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme PB - PubMed Central DO - 10.3389/fpsyt.2022.886407 UR - https://doi.org/10.3389/fpsyt.2022.886407 ER -
APA
Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme. (n.d.). PubMed Central. https://doi.org/10.3389/fpsyt.2022.886407
Related entries
- Establishing the Feasibility of Group Metacognitive Therapy for Anxiety and Depression in Cardiac Rehabilitation: A Single-Blind Randomized Pilot Study
- Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT)
- Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial
- Metacognitive Therapy Self-Help for Anxiety-Depression: Single-Blind Randomized Feasibility Trial in Cardiovascular Disease
- Cardiac rehabilitation patients experiences and understanding of group metacognitive therapy: a qualitative study
- Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation
- Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial
- Protocol for an implementation study of group metacognitive therapy for anxiety and depression in NHS cardiac rehabilitation services in England (PATHWAY-Beacons)
- Qualitative Analysis of Emotional Distress in Cardiac Patients From the Perspectives of Cognitive Behavioral and Metacognitive Theories: Why Might Cognitive Behavioral Therapy Have Limited Benefit, and Might Metacognitive Therapy Be More Effective?
- Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial